Avalo Therapeutics, Inc. ($AVTX)
Doyle Mittie โ Chief Medical Officer
Shares
5,992
Price
$8.04
Total Value
$48,175.68
Nearby Earnings
Mar 19, 2026
EPS:Est: -1.46
Mar 23, 2026
EPS:-1.02 (est: -1.46)-29.8%
Revenue:-$209.00K
Transaction Details
| Insider | Doyle Mittie |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | Mar 16, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 18, 2026 |
| Shares Purchased | 5,992 |
| Price per Share | $8.04 |
| Total Value | $48,175.68 |
| Shares Owned After | 29,114 |
| Derivative | No |
| Accession Number | 0001918845-26-000004 |
| Document | View SEC Filing |